Key result
Multimodal imaging and biopsy diagnose cardiac sarcoidosis, guiding ICD therapy that successfully terminates VT.
Why the study?
Cardiac sarcoidosis and myocarditis share clinical and histopathological features, making a definitive diagnosis challenging despite multimodality imaging, endomyocardial biopsy, and a multidisciplinary team approach.
Case Report (n=1)
No
This case report highlights that differentiating cardiac sarcoidosis from myocarditis cannot rely on any single test (such as endomyocardial biopsy or PET/CT alone), requiring an integrated multimodality imaging and multidisciplinary team approach to guide appropriate therapy and ICD implantation.
Answers are grounded in this paper and cite their sources.
Supports multidisciplinary diagnosis of cardiac sarcoidosis to guide ICD decisions; leaves open prospective validation in larger cohorts.
Cardiac sarcoidosis and myocarditis both can share histopathological and clinical features, making a distinct diagnosis challenging. Myocarditis is presently regarded as a distinct entity with solely cardiac manifestation, a rapidly progressive clinical course, and a poorer prognosis, whereas cardiac sarcoidosis is a systemic disorder with slower disease progression. However, both conditions can present similarly, often manifesting with high-degree atrioventricular block, ventricular tachyarrhythmias, and heart failure. Despite the use of multimodality imaging, endomyocardial biopsy, and a multidisciplinary team approach, which is considered the current gold standard, making a definitive diagnosis remains challenging. This case report illustrates the necessity of an integrated, multimodal multidisciplinary approach to navigate these clinical challenges and to guide the selection of appropriate tailored treatment strategies.
No takes yet. Share an insight, caveat, or question.
Richard P. Allwood (2026) conducted a case report in Cardiac sarcoidosis versus myocarditis (n=1). Multimodality imaging, endomyocardial biopsy, guideline-directed medical therapy (perindopril, metoprolol succinate), and dual-chamber implantable cardioverter-defibrillator implantation was evaluated on Clinical diagnosis of cardiac sarcoidosis and clinical stability with arrhythmia management. A multimodal multidisciplinary approach combining cardiac MRI, PET/CT, and biopsy diagnosed cardiac sarcoidosis in a patient with LVEF 40%, leading to ICD therapy that terminated VT up to 250 bpm.
Synapse has enriched 10 related papers. Consider them for comparative context: